Anti-Cancer Agents in Medicinal Chemistry
Title:Acknowledgements to Reviewers
Volume: 19 Issue: 18
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Acknowledgements to Reviewers, Anti-Cancer Agents in Medicinal Chemistry 2019; 19 (18) . https://dx.doi.org/10.2174/187152061918200114104845
DOI https://dx.doi.org/10.2174/187152061918200114104845 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
4
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development of Immunopharmacotherapy Against Drugs of Abuse
Current Drug Discovery Technologies Immunoliposomes
Current Medicinal Chemistry Artemisinin, Promising Lead Natural Product for Various Drug Developments
Mini-Reviews in Medicinal Chemistry The Orvinols and Related Opioids - High Affinity Ligands with Diverse Efficacy Profiles
Current Pharmaceutical Design Obesity in the Patient with Lung Disease
Current Respiratory Medicine Reviews Spatiotemporal Regulation of DNA Replication in the Human Genome and its Association with Genomic Instability and Disease
Current Medicinal Chemistry Protein-inorganic Nanohybrids: A Potential Symbiosis in Tissue Engineering
Current Drug Targets PRDM14: A Potential Target for Cancer Therapy
Current Cancer Drug Targets Frontier Lipid-Based Carrier Systems for Drug Targeting: A Laconic Review on Niosomes
Pharmaceutical Nanotechnology The Roles of MicroRNAs in Heart Diseases: A Novel Important Regulator
Current Medicinal Chemistry Perfluoroalkylsulfonyloxyisoflavones: Synthesis and Anti-Proliferation of HL-60
Letters in Organic Chemistry Compounds from Wild Mushrooms with Antitumor Potential
Anti-Cancer Agents in Medicinal Chemistry DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer
Current Cancer Drug Targets Obesity and Arterial Compliance Alterations
Current Vascular Pharmacology Near Infrared Spectroscopic Combined with Partial Least Squares and Radial Basis Function Neural Network to Analyze Paclitaxel Concentration in Rat Plasma
Combinatorial Chemistry & High Throughput Screening The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
Current Molecular Medicine Sunflower Trypsin Inhibitor 1 as a Molecular Scaffold for Drug Discovery
Current Pharmaceutical Design Pluronic-Based Core/Shell Nanoparticles for Drug Delivery and Diagnosis
Current Medicinal Chemistry Part I: Targeted Particles for Cancer Immunotherapy
Current Drug Delivery The NK-1 Receptor: A New Target in Cancer Therapy
Current Drug Targets